Investment
Features
FeesSafety
Academy
More
Pluang+

AZZ Inc. schedules Q2 FY2027 earnings call for October 14, with results out October 13.

Company Fundamentals
23 Sep 2026
PRNewsWire
View Source
Neutral
AZZ Inc. schedules Q2 FY2027 earnings call for October 14, with results out October 13.

AZZ Inc., a leading provider of hot-dip galvanizing and coil coating solutions, announced it will release its second quarter fiscal year 2027 financial results on October 13, 2026, after market close. The company will hold a conference call to discuss these results on October 14, 2026. This update is important for investors tracking AZZ's performance amid market and economic uncertainties affecting production costs and demand. The call and replay will be accessible via phone and webcast on AZZ's investor relations website.

AZZ Inc.'s upcoming Q2 fiscal year 2027 financial results provide context for industrial sector investors. For readers following Industrials, here is Pluang's market snapshot as of Sep 24, 2026 03:02 WIB: out of 93 priced stocks, 40 rose and 53 fell. Notable movers include RDW at USD 11.28 with a -4.08% change and a typical hold time of 16 days, ADT at USD 6.63 down 3.91%, and CTAS at USD 191.70 down 3.57%.

More News

BlackBerry set to report Q3 earnings with strong QNX growth and cybersecurity gains.

BlackBerry set to report Q3 earnings with strong QNX growth and cybersecurity gains.

BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...

Company Fundamentals
Bullish
51 minutes ago
WHLR jumps 191%, ARTL rises on obesity drug patent news, FSLY and IPDN also surge

WHLR jumps 191%, ARTL rises on obesity drug patent news, FSLY and IPDN also surge

Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...

Market News
Bullish
51 minutes ago
Jaguar Health and Alkami lead sharp stock declines on September 23, with no clear causes for most drops.

Jaguar Health and Alkami lead sharp stock declines on September 23, with no clear causes for most drops.

On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...

Market News
Bearish
51 minutes ago
Costco reports strong Q4 sales growth ahead of full earnings release on Sept 24

Costco reports strong Q4 sales growth ahead of full earnings release on Sept 24

Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...

Company Fundamentals
Neutral
1 hour ago
Jefferies maintains Buy rating on Life Time amid $6.5M insider stock sales by executive.

Jefferies maintains Buy rating on Life Time amid $6.5M insider stock sales by executive.

Jefferies reaffirmed its Buy rating on Life Time Group Holdings (LTH), citing a positive earnings outlook supported by a Zacks Rank of #2. The stock trades around $38.85 with a market cap near $8.68 billion. Despite this optimism, Executive Vice Pres...

Analyst Insights
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App